𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen–negative chronic hepatitis B virus infection

✍ Scribed by George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Athanasios J. Archimandritis


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
52 KB
Volume
46
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255-260. 6. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-438. 7. Magness ST, Bataller R, Yang L, Brenner D. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. HEPATOLOGY 2004;40:1151-1159. 8. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrowderived progenitor cells in pulmonary fibrosis.


📜 SIMILAR VOLUMES


Is there a meaningful serum hepatitis B
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Ioannis S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

The diagnosis of hepatitis B e antigen (HBeAg)-negative chronic hepatitis B indicating therapeutic intervention currently requires serum hepatitis B virus (HBV) DNA >2,000 IU/mL. We evaluated the severity of liver histology and the presence of histological indication for treatment in patients with H

Leucocyte hepatitis B virus DNA in acute
✍ F. Davison; G. J. M. Alexander; Ch. Anastassakos; E. A. Fagan; Roger Williams 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

In the present study we have investigated 53 patients with a spectrum of acute and chronic hepatitis B virus (HBV) infection for the presence of leucocyte HBV-DNA with the aid of molecular techniques. HBV-DNA was detected in peripheral blood mononuclear cells of 31 of 45 (69%) of chronic HBsAg carri

Hepatitis B virus DNA levels and outcome
✍ Chien-Jen Chen; Hwai-I Yang; Uchenna H. Iloeje; The REVEAL-HBV Study Group 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 1 views

Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of chronic HBV infection. Both case-control and cohort studies have shown a significant, dose-response association between serum HBV DNA levels measured at the time of initial evaluation and the subsequent risk of cirr

Efficacy of lamivudine in patients with
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Natural history of chronic hepatitis B v
✍ Chia-Ming Chu; Peter Karayiannis; Martin J. F. Fowler; Jon Monjardino; Yun-Fan L 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 1 views

Hepatitis B virus DNA (HBV DNA) in serum was measured by a Spot hybridization technique in a consecutive series of 79 cases with chronic HBV infection from Taiwan. HBV DNA was found in 96.3% (52/54) of HBeAg-positive, 66% (2/3) with neither ABeAg or anti-HBe and in 63.6% (14/ 22) of anti-HBe positiv

Hepatitis B infection of the liver in ch
✍ Luisa Fernanda Mariscal; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Cas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 2 views

## Abstract Hepatitis B virus (HBV) DNA may persist in the liver in the absence of serum HBV–DNA after a self‐limited acute hepatitis B. This may also occur in patients with chronic hepatitis C virus (HCV) infection but its prevalence and its impact on liver histology is unknown. HBV–DNA was tested